Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1984 1
1985 2
1986 1
1988 1
1998 1
2001 2
2002 1
2003 1
2004 3
2005 3
2006 4
2007 3
2008 5
2009 3
2010 8
2011 6
2012 1
2013 1
2014 3
2015 7
2016 6
2017 3
2018 7
2019 5
2020 7
2021 3
2022 3
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Piperaquine: a resurgent antimalarial drug.
Davis TM, Hung TY, Sim IK, Karunajeewa HA, Ilett KF. Davis TM, et al. Among authors: karunajeewa ha. Drugs. 2005;65(1):75-87. doi: 10.2165/00003495-200565010-00004. Drugs. 2005. PMID: 15610051 Review.
Primaquine for Plasmodium vivax malaria treatment.
Karunajeewa H, James R. Karunajeewa H, et al. Lancet. 2020 Jun 27;395(10242):1971-1972. doi: 10.1016/S0140-6736(20)30242-7. Lancet. 2020. PMID: 32593332 No abstract available.
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis.
Rajasekhar M, Simpson JA, Ley B, Edler P, Chu CS, Abreha T, Awab GR, Baird JK, Bancone G, Barber BE, Grigg MJ, Hwang J, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Llanos-Cuentas A, Pukrittayakamee S, Rijal KR, Saravu K, Sutanto I, Taylor WRJ, Thriemer K, Watson JA, Guerin PJ, White NJ, Price RN, Commons RJ; WorldWide Antimalarial Resistance Network (WWARN) Vivax Primaquine Dosing Efficacy, Tolerability and Safety Study Group. Rajasekhar M, et al. Among authors: karunajeewa h. Lancet Infect Dis. 2024 Feb;24(2):184-195. doi: 10.1016/S1473-3099(23)00431-0. Epub 2023 Sep 22. Lancet Infect Dis. 2024. PMID: 37748497 Free PMC article.
Lead poisoning associated with illicit opium use.
Wong J, Bourke E, Roberts V, Lim SM, Johnson D, Hamblin PS, Karunajeewa H, Greene S. Wong J, et al. Among authors: karunajeewa h. Intern Med J. 2020 Feb;50(2):239-242. doi: 10.1111/imj.14729. Intern Med J. 2020. PMID: 32037702
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
Mehdipour P, Rajasekhar M, Dini S, Zaloumis S, Abreha T, Adam I, Awab GR, Baird JK, Brasil LW, Chu CS, Cui L, Daher A, do Socorro M Gomes M, Gonzalez-Ceron L, Hwang J, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Leslie T, Ley B, Lidia K, Llanos-Cuentas A, Longley RJ, Monteiro WM, Pereira DB, Rijal KR, Saravu K, Sutanto I, Taylor WRJ, Thanh PV, Thriemer K, Vieira JLF, White NJ, Zuluaga-Idarraga LM, Guerin PJ, Price RN, Simpson JA, Commons RJ; WWARN Vivax Adherence Study Group. Mehdipour P, et al. Among authors: karunajeewa h. Malar J. 2023 Oct 10;22(1):306. doi: 10.1186/s12936-023-04725-w. Malar J. 2023. PMID: 37817240 Free PMC article.
89 results